Article 13 Oct 2022 Patented Medicines Prices Review Board (PMPRB) Releases New Draft Guidelines Canada IP
Article 18 Apr 2022 Launch Of Ontario's Life Sciences Strategy Coincides With Announcement Of Investment In OmniaBio Inc. Biomanufacturing Facility Canada Healthcare
Article 29 Mar 2022 IP Transactions In Life Sciences: Data Transfer, Sharing And Exclusivity In China And Canada Worldwide IP
Article 30 Dec 2021 Amendments To The Patented Medicines Regulations Delayed Six Months, Until July 1, 2022 Canada IP
Article 17 Sep 2021 Providence Therapeutics And Everest Medicines Enter Into Comprehensive Agreements To Advance MRNA Vaccines And Therapies In Asia Emerging Markets Canada Healthcare
Article 15 Jul 2020 Keeping A Secret: Five Tips For Creating An Effective Non-Disclosure Agreement Canada IP